Showing results (1-10 of 286) with videos related to
Sort By:
Pageof 29
Therapeutic Innovation & Regulatory Science|May 9, 2025
Consideration for Assessing Data/Models/Tools Expiration Supporting Drug Development and Clinical Decision MakingJeffrey S Barrett, Mark A TurnerPediatric Research|March 2, 2017
Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonatesRobert M Ward, Daniel Benjamin, Jeffrey S Barrett, et al.British Journal of Clinical Pharmacology|November 21, 2013
Paediatric models in motion: requirements for model-based decision support at the bedsideJeffrey S BarrettBritish Journal of Clinical Pharmacology|October 30, 2020
Risk assessment of therapeutic agents under consideration to treat COVID-19 in paediatric patients and pregnant womenJeffrey S BarrettThe AAPS Journal|May 1, 2008
The role of quantitative pharmacology in an academic translational research environmentJeffrey S BarrettJournal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Facilitating compound progression of antiretroviral agents via modeling and simulationJeffrey S BarrettCPT: Pharmacometrics & Systems Pharmacology|April 12, 2022
Quantitative system pharmacology as a legitimate approach to examine extrapolation strategies used to support pediatric drug developmentKarim Azer, Jeffrey S BarrettJournal of Clinical Pharmacology|June 15, 2023
Opportunities for Systems Biology and Quantitative Systems Pharmacology to Address Knowledge Gaps for Drug Development in PregnancyJeffrey S Barrett, Karim AzerPsychosomatics|December 31, 2005
Factitious disorders: reformulating the DSM-IV criteriaMark A TurnerBritish Journal of Clinical Pharmacology|July 22, 2014
Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conductMark A TurnerPageof 29